Auro-Tenofovir

Active ingredients

• Tenofovir Disoproxil Fumarate — 300 mg

Form and route

Tablet · Oral

Schedule

PRESCRIPTION

Authorised since

2017-07-26

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

• Viread02247128Gilead Sciences Canada IncTenofovir Disoproxil Fumarate 300 mgTablet
• Teva-Tenofovir02403889Teva Canada LimitedTenofovir Disoproxil Fumarate 300 mgTablet
• Apo-Tenofovir02451980Apotex IncTenofovir Disoproxil Fumarate 300 mgTablet
• Mylan-Tenofovir Disoproxil02452634Mylan Pharmaceuticals ULCTenofovir Disoproxil Fumarate 300 mgTablet
• PMS-Tenofovir02453940Pharmascience IncTenofovir Disoproxil Fumarate 300 mgTablet
• Nat-Tenofovir02472511Natco Pharma (Canada) IncTenofovir Disoproxil Fumarate 300 mgTablet
• Jamp-Tenofovir02479087Jamp Pharma CorporationTenofovir Disoproxil Fumarate 300 mgTablet
• Tenofovir02512327Sanis Health IncTenofovir Disoproxil Fumarate 300 mgTablet
• Mint-Tenofovir02512939Mint Pharmaceuticals IncTenofovir Disoproxil Fumarate 300 mgTablet
• Riva-Tenofovir02515156Laboratoire Riva Inc.Tenofovir Disoproxil Fumarate 300 mgTablet
• AG-Tenofovir02516276Angita Pharma Inc.Tenofovir Disoproxil Fumarate 300 mgTablet
• Tenofovir02523922Sivem Pharmaceuticals ULCTenofovir Disoproxil Fumarate 300 mgTablet

Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

Anatomical main group

Anti-infectives for systemic use

ATC code

J05AF07

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of J05AF07, see the WHO ATC/DDD Index.